Pulsed fast neutron analysis system used in security surveillance.
Clasificación: | Libro Electrónico |
---|---|
Autor Corporativo: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Bethesda, Maryland :
National Council on Radiation Protection and Measurements,
©2003.
|
Colección: | NCRP commentary ;
no. 17. |
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- ""Cover ""; ""Preface""; ""Contents""; ""1. Summary""; ""1.1 The Appropriate Dose Limit for Persons Inadvertently Irradiated by the Pulsed Fast Neutron Analysis System""; ""1.2 Effective Dose""; ""1.3 Neutron Activation in Pharmaceuticals and Medical Devices""; ""1.4 Applicable Radiation Protection Concepts for Workers and Members of the Public""; ""1.5 The “As Low As Reasonably Achievable� Principle and Its Application to the Pulsed Fast Neutron Analysis Facility""; ""1.6 Advice on the System Safety Specifications and the Radiation Safety Plan""
- 1.7 Potential Effects on Nuclear Weapons in Scanned Cargo1.8 Approach to Determination of Effective Dose for Inadvertently Exposed Individuals
- 1.9 Determination of Effective Dose for Inadvertently Exposed Individuals
- 1.10 Validation Measurements and Uncertainties
- 1.11 Application of the Results
- 1.12 Quality Control of Pulsed Fast Neutron Analysis System Performance
- 2. The Appropriate Dose Limit for Inadvertently Exposed Individuals and Levels of Activation Products in Pharmaceuticals and Medical Devices
- 2.1 Introduction
- 2.2 The Appropriate Dose Limit
- 2.2.1 Prior NCRP Recommendations2.2.2 Recommendations for the Pulsed Fast Neutron Analysis System
- 2.3 Determination of Effective Dose
- 2.3.1 Dosimetry Approach
- 2.3.2 Effective Dose Formulation
- 2.3.3 Specific Application to Monte Carlo Calculations
- 2.4 Neutron Activation in Pharmaceuticals and Medical Devices
- 2.4.1 Approach to Analysis of Neutron Activation Products
- 2.4.2 Neutron Activation Products for the Pulsed Fast Neutron Analysis System
- 2.4.3 Activation Products in Pharmaceuticals Uniformly Distributed in the Body
- ""2.4.4 Activation Products in Implanted Medical Devices""""2.5 Conclusions""; ""2.5.1 The Appropriate Dose Limit""; ""2.5.2 Determination of Effective Dose""; ""2.5.3 Neutron Activation in Pharmaceuticals and Medical Devices""; ""3. The “As Low As Reasonably Achievable"" Principle and Related Issues""; ""3.1 Introduction""; ""3.2 Description of a Pulsed Fast Neutron Analysis Facility""; ""3.3 Principles of Radiation Protection""; ""3.3.1 Effects of Concern in Radiation Protection""; ""3.3.2 The Radiation Protection System""; ""3.4 “As Low as Reasonably Achievable� Philosophy""
- ""3.4.1 Application of “As Low As Reasonably Achievable� to the Pulsed Fast Neutron Analysis Facility""""3.4.2 Radiation Levels at the Inspection Station""; ""3.4.3 Doses from Inadvertent Exposure""; ""3.4.4 Activation Products in Food, Pharmaceuticals, Medical Devices, and Other Cargo""; ""3.4.5 Radiation Levels Outside the Facility""; ""3.5 System Safety Specifications""; ""3.6 Radiation Safety Plan""; ""3.6.1 Radiological Area Classifications""; ""3.6.2 Access Controls""; ""3.6.3 Radiation Detection and Monitoring""; ""3.6.4 Interlocks and Emergency Switches""; ""3.6.5 Shielding""